Frontiers | Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients
---Azide-and-BSA-Free-Flow-Cytometry-NBP2-33068-img0002.jpg "EGFR Antibody (GFR450) - Azide and BSA Free (NBP2-33068): Novus Biologicals")
EGFR Antibody (GFR450) - Azide and BSA Free (NBP2-33068): Novus Biologicals
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer | Molecular Pharmaceutics
Epidermal growth factor receptor - Wikipedia
Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling - ScienceDirect
Cancers | Free Full-Text | Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications | Signal Transduction and Targeted Therapy
Comparison of EGFR positive test results obtained with | Download Table
Frontiers | EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer
Results for "DNA polymerase" | Abcam: antibodies, proteins, kits...
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC) - eBioMedicine
IJMS | Free Full-Text | The Role of EREG/EGFR Pathway in Tumor Progression
Switching off DNA repair—how colorectal cancer evades targeted therapies through adaptive mutability | Signal Transduction and Targeted Therapy
Cigarette smoke enhances oncogene addiction to c‐MET and desensitizes EGFR‐expressing non‐small cell lung cancer to EGFR TKIs - Tu - 2018 - Molecular Oncology - Wiley Online Library
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
EGFR Monoclonal Antibody (H11) (MA5-13070)
Regulation of the error-prone DNA polymerase polκ by oncogenic signaling and its contribution to drug resistance | bioRxiv
Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation | Oncotarget
Post-Translational Modifications of PCNA in Control of DNA Synthesis and DNA Damage Tolerance-the Implications in Carcinogenesis
EGFR and NF-κB: partners in cancer: Trends in Molecular Medicine
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Translesion Synthesis or Repair by Specialized DNA Polymerases Limits Excessive Genomic Instability upon Replication Stress
Matuzumab Biosimilar, Research Grade | EGFR mAb - Ushelf
EGFR/HER-targeted therapeutics in ovarian cancer | Future Medicinal Chemistry
